In conclusion, our quantitative assessment of cancer stem cell markers revealed their unique expression patterns in right colon cancer, and moreover, we herein concluded that all the stem cell markers (CD44V, CD133, and Ascl2) investigated in our current study can not represent metastatic markers by themselves. The gene discussed is PROM1; the disease is colonic neoplasm.